BDNF and glioma: Sharma and colleagues proposed the involvement of MeCP2 in glioma by showing that MeCP2 overexpression can inhibit proliferation, migration, invasion, and adhesion while inhibiting malignant behavior in glioma cells by inhibiting pERK and BDNF and inducing GFAP [136].